News

Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.
FDA issues warning as NuNaturals sweeteners recalled because of mislabeling
Two different NuNaturals sweeteners were given the second-highest risk warning by the FDA. Here's what that means.
Former FDA chief challenges agency to bar certain ultraprocessed food ingredients
The former head of the US Food and Drug Administration is testing the Trump administration’s commitment to “Make America ...
Smart Labels Market Insights and Forecasts, 2021-20245 & 2025-2031 | Rising Compliance Regulations Boost Adoption in Healthcare and Food Industries
Explore the comprehensive analysis of the Global Smart Labels Market segmented by technology, application, and end-use industry for 2021-2031. The smart labels market, valued at USD 10.09 billion in ...
Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback
Detailed price information for Ensysce Biosciences Inc (ENSC-Q) from The Globe and Mail including charting and trades.
Applied Clinical Trials Online13d
FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
FDA gets feedback on proposed front-of-pack nutrition label
Meanwhile, the Consumer Brands Association continues to push for the existing industry-led Facts up Front label.